ICL to acquire the activity of Evogene's subsidiary, Lavie Bio
Date：Apr. 22, 2025
Print this page.
Lavie, a fully owned subsidiary of Evogene (NASDAQ:EVGN), aims to improve food quality, sustainability and agriculture productivity through the introduction of microbiome based ag-biological products. Lavie utilizes a proprietary computational predictive platform, harnessing the power of big data and advanced informatics, for the discovery, optimization and development of bio-stimulants and bio-pesticides products. Lavie has an ongoing collaboration with industry leader Corteva for the development of seed applied corn bio-stimulants.
| Find this article at: http://www.agropages.com/CompanyDirectory/Detail-20930.htm | |
| Souce: | Agropages.com |
|---|---|
| Web: | www.agropages.com |
| Contact: | info@agropages.com |
